Shiseido Company, Limited (”Shiseido”) has announced that a resolution was adopted by the Board of Directors on December 20, 2023, upon discretionary approval of the Representative Director for the terms and conditions, to acquire DDG Skincare Holdings LLC (”DDG,” headquartered in New York, USA).
DDG is a leading company offering dermatologist-led, science-based prestige skincare. To complete this transaction, Shiseido Americas Corporation, a consolidated subsidiary of Shiseido has signed a definitive agreement to acquire DDG on December 22, 2023.
With this acquisition, Shiseido expects to see a growing interest in health and beauty as consumers increase their awareness of “skin health.” As a derma cosmetics, doctor-led brand Dr. Dennis Gross Skincare strengthens Shiseido’s position in a rapidly growing skincare segment.
By tapping the great potential of the growing market in the U.S. with its unique positioning coupled with a complementary fit with its prestige portfolio, this will be a strategic addition to Shiseido along with the company’s prestige beauty brands SHISEIDO and Clé de Peau Beauté.
The acquisition of a high-growth, profit accretive skincare brand will also contribute to the ongoing expansion of the Americas business, a strategically important region for Shiseido. This will enable the company to diversify its geographical footprint while resolving the imbalances in its revenue streams.
With a philosophy rooted in research, dermatology and technology, the brand is well aligned with Shiseido’s rich heritage in skincare, global platforms, and R＆D capabilities. This will in turn support Dr. Dennis Gross Skincare to accelerate its next phase of growth. Together, both companies will be well positioned to capture opportunities in the rapidly growing doctor-led skincare market around the world.
Source
